טוען...
SARS-CoV-2 RNA-dependent RNA polymerase as a therapeutic target for COVID-19
Introduction: The current SARS-CoV-2 pandemic urgently demands for both prevention and treatment strategies. RNA-dependent RNA-polymerase (RdRp), which has no counterpart in human cells, is an excellent target for drug development. Given the time-consuming process of drug development, repurposing dr...
שמור ב:
| הוצא לאור ב: | Expert Opin Ther Pat |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Taylor & Francis
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7938656/ https://ncbi.nlm.nih.gov/pubmed/33475441 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/13543776.2021.1880568 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|